Eli Lilly & Co. – Detailed Financial Charts & Data

Timeframe

Revenue by segment

Revenue by segment – (Table representation)

SEC report release date
Net product revenue
Collaboration and other revenue
SEC report date:30 Apr. 26
Net product revenue:
18,453,000,000 $
Collaboration and other revenue:
1,346,000,000 $
SEC report date:12 Feb. 26
Net product revenue:
18,300,300,000 $
Collaboration and other revenue:
991,700,000 $
SEC report date:30 Oct. 25
Net product revenue:
16,330,500,000 $
Collaboration and other revenue:
1,270,300,000 $
SEC report date:07 Aug. 25
Net product revenue:
14,726,000,000 $
Collaboration and other revenue:
831,700,000 $
SEC report date:01 May. 25
Net product revenue:
11,601,200,000 $
Collaboration and other revenue:
1,127,300,000 $
SEC report date:19 Feb. 25
Net product revenue:
12,024,900,000 $
Collaboration and other revenue:
1,507,900,000 $
SEC report date:30 Oct. 24
Net product revenue:
10,571,600,000 $
Collaboration and other revenue:
867,500,000 $
SEC report date:08 Aug. 24
Net product revenue:
10,354,900,000 $
Collaboration and other revenue:
947,900,000 $
SEC report date:30 Apr. 24
Net product revenue:
7,796,500,000 $
Collaboration and other revenue:
971,500,000 $
SEC report date:21 Feb. 24
Net product revenue:
8,289,700,000 $
Collaboration and other revenue:
1,063,700,000 $
SEC report date:02 Nov. 23
Net product revenue:
7,306,200,000 $
Collaboration and other revenue:
2,192,400,000 $
SEC report date:08 Aug. 23
Net product revenue:
6,979,800,000 $
Collaboration and other revenue:
1,332,300,000 $
SEC report date:27 Apr. 23
Net product revenue:
6,238,200,000 $
Collaboration and other revenue:
721,800,000 $
Expand table